Superion IDE Trial
VertiFlex® is conducting an IDE trial in the United States on the Superion Interspinous Spacer System. 31 prestigious U.S. spine centers are involved, with both spine surgeons and interventional spine physicians serving as the trial’s principal investigators.
Enrollment was completed with 470 patients in December, 2011.
Superion Interspinous Spacer IDE Trial Information
Click below to learn more about the trial.
Caution: Restricted by U.S. law to investigational use only© 2015 VertiFlex Inc.